soluble factor inoculation human monocytes Leishmania donovani IFN-gamma-dependent monocyte activation Whereas human monocytes IFN-gamma antileishmanial capacity monocytes Leishmania donovani IFN-gamma treatment fail increase antileishmanial capacity Cell surface expression class II MHC products IFN-gamma infected monocytes accumulation HLA-DR alpha-chain mRNA extent infected noninfected activated monocytes inhibition monocyte activation dose-dependent manner soluble substance cell supernatant inoculation monocytes donovani activation factor ASF activity dialysis treatment proteinase ASF small peptide 